ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Emergent Biosolutions Inc

Emergent Biosolutions Inc (EBS)

3.20
-0.10
(-3.03%)
Closed February 28 04:00PM
3.28
0.08
(2.50%)
After Hours: 07:52PM

Calls

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
0.502.403.402.802.900.6530.23 %27272/28/2024
1.002.102.702.002.400.000.00 %044-
1.501.602.152.031.8750.2816.00 %15262/28/2024
2.001.351.501.401.425-0.05-3.45 %682132/28/2024
2.500.851.201.051.0250.099.38 %1382,5542/28/2024
5.000.250.300.250.275-0.04-13.79 %6568,5752/28/2024
7.500.050.100.080.075-0.03-27.27 %202,5472/28/2024
10.000.050.150.050.10-0.05-50.00 %194,1802/28/2024
12.500.050.050.050.050.000.00 %04,203-

Puts

StrikeBid PriceAsk PriceLast PriceMidpointChangeChange %VolumeOPEN INTLast Trade
0.500.050.050.050.050.000.00 %01-
1.000.050.050.050.050.000.00 %0510-
1.500.050.050.030.05-0.02-40.00 %52842/28/2024
2.000.100.150.140.1250.07100.00 %763352/28/2024
2.500.200.300.260.25-0.09-25.71 %361,4492/28/2024
5.001.852.152.052.00-0.15-6.82 %83092/28/2024
7.504.204.504.394.35-0.43-8.92 %32492/28/2024
10.006.607.007.106.800.000.00 %081-
12.509.009.509.409.250.000.00 %01-

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
VANIVivani Medical Inc
$ 3.6305
(259.46%)
148.8M
VTVTvTv Therapeutics Inc
$ 16.848
(98.21%)
3.06M
ADILAdial Pharmaceuticals Inc
$ 1.60
(83.21%)
111.63M
COCHEnvoy Medical Inc
$ 2.21
(78.23%)
2.82M
BETSBit Brother Ltd
$ 4.18
(67.87%)
60.01M
CRGECharge Enterprises Inc
$ 0.0253
(-57.83%)
97.17M
IASIntergral Ad Science Holding Corporation
$ 10.02
(-41.40%)
15.75M
SMXSMX Security Matters Public Company
$ 0.2183
(-37.61%)
19.86M
INGNInogen Inc
$ 6.29
(-32.66%)
2.83M
PRSTPresto Technologies Inc
$ 0.3975
(-30.26%)
26.78M
MARAMarathon Digital Holdings Inc
$ 31.00
(2.28%)
179.65M
VANIVivani Medical Inc
$ 3.6305
(259.46%)
148.8M
NKLANikola Corporation
$ 0.7684
(1.67%)
121.41M
SOUNSoundHound AI Inc
$ 6.3201
(-7.87%)
118.47M
GOEVCanoo Inc
$ 0.10675
(-6.20%)
114.23M

EBS Discussion

View Posts
Monksdream Monksdream 2 days ago
Well alright then
Socially responsible company
We wait
👍️ 1
allenc allenc 2 days ago
After Market close
๐Ÿ‘๏ธ0
Monksdream Monksdream 2 days ago
EBS 10Q 2/27
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 1 week ago
EBS: The hands-down WINNER of this day!!! EASY FRICKIN' MONEY!!!
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 week ago
EBS now No 1 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 week ago
EBS No 3 on the Barchart 100
https://www.barchart.com/stocks/performance/percent-change/advances?timeFrame=today&viewName=main&screener=overall&orderBy=percentChange&orderDir=desc
๐Ÿ‘๏ธ0
Invest-in-America Invest-in-America 1 week ago
EBS: Got new CEO, who wants to drive this Firm to the BIG TIME!!
๐Ÿ‘๏ธ0
allenc allenc 3 weeks ago
Lets see what happens when the financials are released. If they hit their sales target with the OTC Narcan, should be nice net profits, JMO
๐Ÿ‘๏ธ0
Monksdream Monksdream 3 weeks ago
EBS new 52 week low
๐Ÿ‘๏ธ0
allenc allenc 4 weeks ago
What is up with this company? Management gonna ride this into the ground and bury it?
๐Ÿ‘๏ธ0
Monksdream Monksdream 1 month ago
EBS new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
EBS new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 4 months ago
EBS new 52 week low
๐Ÿ‘๏ธ0
Biggiee Biggiee 5 months ago
Heaping pile of company. Havenโ€™t seen this kind of incompetence in all my years of trading! Narcan everywhere! And this company is collapsing!
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
EBS new 52 week low
๐Ÿ‘๏ธ0
Monksdream Monksdream 5 months ago
EBS new 52 week low
๐Ÿ‘๏ธ0
Biggiee Biggiee 5 months ago
Iโ€™m starting to shift opinions on thisโ€ฆ might be a turd of a company. There has to be something seriously rotten here for SP to plummet through 52 week lows.
GL
๐Ÿ‘๏ธ0
Biggiee Biggiee 6 months ago
This has not gone the way it should.
Hmmmโ€ฆ.
๐Ÿ‘๏ธ0
Biggiee Biggiee 6 months ago
Iโ€™m sure a lot of competitors will try, but Narcan is proven, trusted and ahead of all of them. If this was a race, the $EBS horse is waaaay ahead. Iโ€™ve learned to stay clear from really long shot ideas that required a lot a praying. IMO, this is the horse to bet on, especially so near 52 week lows.
GL
๐Ÿ‘๏ธ0
Piola Piola 6 months ago
Hi;
Iโ€™m long for EBS. I think it has great potential.
I just have a question. Iโ€™ve read that RiVive will come up with its own nasal narcan. Will this have significant impact on EBS?
Doc
๐Ÿ‘๏ธ0
Biggiee Biggiee 6 months ago
18% short interest. This could run big into September when Narcan shows up in stores and gets local/national news
GL $EBS
๐Ÿ‘๏ธ0
Biggiee Biggiee 6 months ago
Narcan for everybody!! $EBS
๐Ÿ‘๏ธ0
TheFinalCD TheFinalCD 7 months ago
https://ih.advfn.com/stock-market/NYSE/emergent-biosolutions-EBS/stock-news/91689294/emergent-biosolutions-awarded-10-year-barda-contra

almost exactly 1 year later
๐Ÿ‘๏ธ0
LearningEveryTrade LearningEveryTrade 2 years ago
Cali State of Emergency https://www.gov.ca.gov/2022/08/01/74502/
๐Ÿ‘๏ธ0
Elgordo84 Elgordo84 2 years ago
Looks like this sleeping Giant
Is getting ready to awake!
Letโ€™s go $EBS
๐Ÿ‘๏ธ0
InkynClyde InkynClyde 2 years ago
Building position
๐Ÿ‘๏ธ0
Cuppy Cuppy 3 years ago
"Emergent was forced to halt operations at its plant in the Bayview area of Baltimore after contamination issues led to millions of spoiled vaccine doses."

https://www.nytimes.com/2021/06/16/us/emergent-biosolutions-covid-vaccine.html?action=click&module=Top%20Stories&pgtype=Homepage

since your recommendation, it has lost half its value.
๐Ÿ‘๏ธ0
T695 T695 3 years ago
Buy buy buy
๐Ÿ‘๏ธ0
T695 T695 3 years ago
One patient got sick out of 60,000.
Buy buy buy
๐Ÿ‘๏ธ0
T695 T695 3 years ago
Gift
๐Ÿ‘๏ธ0
GoSlowDudes GoSlowDudes 4 years ago
EPS

2019 $2.88
2020 $6.59
2021 $7.96

P/E = 14.70 on next years earnings. Cheap stock compared to S &P which is in the mid 20โ€™s depending on which one you use.
๐Ÿ‘๏ธ0
Hitman970 Hitman970 4 years ago
Cannon! Bull Flag Alert!!!!
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago


Emergent BioSolutions Signs Development and Manufacturing Agreement with Vaxart for their Experimental Oral Vaccine Candidate for Coronavirus Disease



GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered into an agreement with Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company, whereby Emergent has agreed to utilize its molecule-to-market contract development and manufacturing (CDMO) services to develop and manufacture Vaxartโ€™s experimental oral vaccine candidate for coronavirus disease (COVID-19). Development services will begin immediately, and upon Vaxartโ€™s election, Emergent agrees to produce clinical material expected to enable Vaxart to initiate a Phase 1 clinical study anticipated early in the second half of 2020. Vaxartโ€™s oral recombinant vaccine candidate is based on its proprietary VAASTโ„ข platform.

โ€œEmergent is pleased to deploy our nimble CDMO expertise to support fellow innovators, like Vaxart, and advance an experimental COVID-19 vaccine candidate,โ€ said Syed T. Husain, senior vice president and CDMO business unit head at Emergent BioSolutions. โ€œWe look forward to applying our broad molecule-to-market services, including our ability to work with a multitude of delivery systems, execute under expedited timelines, and meet Vaxartโ€™s potential need for future scalability and large-scale capacity for commercial quantities.โ€
Under the terms of the agreement, Emergent will provide development services out of its Gaithersburg, Md. location and manufacture drug substance at its Bayview facility in Baltimore, Md., designated a Center for Innovation in Advanced Development and Manufacturing (CIADM) by the U.S. Department of Health and Human Services. Emergentโ€™s Bayview CIADM is the same facility used to manufacture drug substance for the companyโ€™s recently announced Novavax collaboration. The facility has the capacity to produce tens to hundreds of millions of doses of vaccine on an annual basis, based upon the platform technology being leveraged. Additionally, it has the unique capability of producing at clinical scale, to get vaccine candidates quickly into the clinic, and in parallel, scaling up to produce commercial volumes to meet customer demand.

โ€œIโ€™m pleased that we are joining forces with an experienced manufacturer such as Emergent to help advance our oral COVID-19 vaccine to the clinic,โ€ said Wouter Latour, MD, chief executive officer of Vaxart. โ€œWe believe an oral vaccine administered using a room temperature-stable tablet may offer enormous logistical advantages in the roll-out of a large vaccination campaign, and Emergent is a great partner to help in this endeavor.โ€

About Emergent BioSolutions
Emergent BioSolutions is a global life sciences company whose mission is to protect and enhance life. Through our specialty products and contract development and manufacturing services, we are dedicated to providing solutions that address public health threats. Through social responsibility, we aim to build healthier and safer communities. We aspire to deliver peace of mind to our patients and customers so they can focus on whatโ€™s most important in their lives. In working together, we envision protecting or enhancing 1 billion lives by 2030. For more information visit www.emergentbiosolutions.com. Find us on LinkedIn and follow us on Twitter @emergentbiosolu and Instagram @life_at_emergent.

Safe Harbor Statement
This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, including statements regarding our ability to advance potential solutions to combat coronavirus disease as well as the anticipated production level and use of the COVID-19 experimental vaccine candidate in a Phase 1 clinical study in the expected timeframe, are forward-looking statements. These forward-looking statements are based on our current intentions, beliefs and expectations regarding future events. We cannot guarantee that any forward-looking statement will be accurate. Investors should realize that if underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could differ materially from our expectations. Investors are, therefore, cautioned not to place undue reliance on any forward-looking statement. Any forward-looking statement speaks only as of the date of this press release, and, except as required by law, we do not undertake to update any forward-looking statement to reflect new information, events or circumstances.
statements.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
BurrowsR@ebsi.com

Media Contact:
Lynn Kieffer
Vice President, Corporate Communications
240-631-3391
KiefferL@ebsi.com


๐Ÿ‘๏ธ0
GM26 GM26 4 years ago
Donโ€™t have the actual contract, but hereโ€™s the link to the PR >> https://investors.emergentbiosolutions.com/news-releases/news-release-details/emergent-biosolutions-signs-development-and-manufacturing-0
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
โ€ฆโ€ฆโ€ฆโ€ฆโ€ฆโ€ฆโ€ฆโ€ฆ....EPS
Mar 2020 04/30/2020 0.01
Dec 2019 02/20/2020 1.57
Sep 2019 11/06/2019 1.21
Jun 2019 08/01/2019 0.12
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
EBS CHART


๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
Does any one know details of VXRT contract ?
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
PE Ratio = 76

๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
EPS =1.03
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
Revenue = $ 1.11B
๐Ÿ‘๏ธ0
TREND1 TREND1 4 years ago
Market Cap=4.89 B

๐Ÿ‘๏ธ0
GM26 GM26 4 years ago
Yeah Iโ€™m not sure why itโ€™s acting this way. Should go back up once news is out on JNJ study on Vaxart oral pill soon.
๐Ÿ‘๏ธ0
BTCDreamer BTCDreamer 4 years ago
And we know how well they're doing today! :)
๐Ÿ‘๏ธ0
mick mick 4 years ago
Emergent Biosolution (EBS)
88.45 ? 4.37 (5.20%)
Volume: 272,203 @07/06/20 11:52:45 AM EDT
Bid Ask Day's Range
- - 84.75 - 88.63
EBS Detailed Quote
๐Ÿ‘๏ธ0
GM26 GM26 4 years ago
And $VXRT ;)
๐Ÿ‘๏ธ0
mick mick 4 years ago
PARTNER WIT $NVAX, $EBS
๐Ÿ‘๏ธ0
grow fast grow fast 7 years ago
VistaTrades issued a BUY signal for EBS on 4.17.17
๐Ÿ‘๏ธ0
stocktrademan stocktrademan 8 years ago
EBS bullish 28.88

stochastics crossing up out of oversold

market overreacted to light vaccine order and may have misinterpreted
http://www.investors.com/news/technology/emergent-biosolutions-stock-plunges-on-light-anthrax-vaccine-order/?ven=YahooCP&src=AURLLED&ven=yahoo

stock usually recovers from these types of dips
low risk high reward chart


๐Ÿ‘๏ธ0
Bluesummers Bluesummers 8 years ago
An amazing company (would love to work for them some day).

Check out the Robinhood app (good for Android or IOS).

You can trade this company using that app for free.

Great way to start trading if you're new to the stock market (IMHO).
๐Ÿ‘๏ธ0
$Pistol Pete$ $Pistol Pete$ 8 years ago
$EBS Daily and Weekly Charts



๐Ÿ‘๏ธ0

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com